Correction: Absence of the full-length breast cancer-associated gene-1 leads to increased expression of insulin-like growth factor signaling axis members (Cancer Research (2006) 66 (7151-1757) DOI: 10.1158/0008-5472.CAN-05-4570);Absence of the full-length breast cancer-associated gene-1 leads to increased expression of insulin-like growth factor signaling axis members

Cancer Research

Volumn 66, Issue 14, 2006, Pages 7151-7157

  Shukla, Vivek ^a   Coumoul, Xavier ^a,c   Cao, Liu ^a   Wang, Rui Hong ^a   Xiao, Cuiying ^a   Xu, Xiaoling ^a   Andò, Sebastiano ^b   Yakar, Shoshana ^a   LeRoith, Derek ^a   Deng, Chuxia ^a  

^a NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES   (United States)

^b UNIVERSITY OF CALABRIA   (Italy)

^c INSERM   (France)

Author keywords

[No Author keywords available]

Indexed keywords

BRCA1 PROTEIN; HISTONE H3; HISTONE H4; INSULIN RECEPTOR SUBSTRATE 1; PROTEIN P53; SOMATOMEDIN;

AGING; ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; BREAST CANCER; BREAST TUMOR; CELL CULTURE; CELL GROWTH; CHROMATIN STRUCTURE; CONTROLLED STUDY; EPIGENETICS; FEMALE; GENE ACTIVITY; GENE REPRESSION; GROWTH INHIBITION; HUMAN; HUMAN CELL; MALE; MAMMARY GLAND; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN BLOOD LEVEL; PROTEIN DEFICIENCY; PROTEIN DNA INTERACTION; PROTEIN EXPRESSION; RNA INTERFERENCE; SIGNAL TRANSDUCTION; TRANSCRIPTION TERMINATION; TUMOR CELL;

EID: 33746912264     PISSN: 00085472     EISSN: 15387445     Source Type: Journal    
DOI: 10.1158/0008-5472.CAN-18-2467     Document Type: Erratum

References (50)

1. Kuro-o M. Disease model: human aging. Trends Mol Med 2001;7:179-81.
2. Liu L, Wylie RC, Andrews LG, et al. Aging, cancer, and nutrition: the DNA methylation connection. Mech Ageing Dev 2003;124:989-98.
3. Benetos A, Waeber B, Izzo J, et al. Influence of age, risk factors, and cardiovascular and renal disease on arterial stiffness: clinical applications. Am J Hypertens 2002;15:1101-8.
4. Krtolica A, Campisi J. Cancer and aging: a model for the cancer promoting effects of the aging stroma. Int J Biochem Cell Biol 2002;34:1401-14.
5. Campisi J. Cancer, aging, and cellular senescence. In Vivo 2000;14:183-8.
6. Campisi J. Fragile fugue: p53 in aging, cancer, and IGF signaling. Nat Med 2004;10:231-2.
7. Cao L, Li W, Kim S, et al. Senescence, aging, and malignant transformation mediated by p53 in mice lacking the Brcal full-length isoform. Genes Dev 2003;17:201-13.
8. Bachelier R, Xu X, Wang X, et al. Normal lymphocyte development and thymic lymphoma formation in Brcal exon-11-deficient mice. Oncogene 2003;22:528-37.
9. Tyner SD, Venkatachalam S, Choi J, et al. p53 mutant mice that display early ageing-associated phenotypes. Nature 2002;415:45-53.
10. Maier B, Gluba W, Bernier B, et al. Modulation of mammalian life span by the short isoform of p53. Genes Dev 2004;18:306-19.
11. Bluher M, Kahn BB, Kahn CR. Extended longevity in mice lacking the insulin receptor in adipose tissue. Science 2003;299:572-4.
12. Holzenberger M, Dupont J, Ducos B, et al. IGF-I receptor regulates lifespan and resistance to oxidative stress in mice. Nature 2003;421:182-7.
13. Xu X, Qiao W, Linke SP, et al. Genetic interactions between tumor suppressors Brcal and p53 in apoptosis, cell cycle, and tumorigenesis. Nat Genet 2001;28:266-71.
14. Yakar S, Liu JL, Stannard B, et al. Normal growth and development in the absence of hepatic insulin-like growth factor I. Proc Natl Acad Sci USA 1999;96:7324-9.
15. Harkin DP, Bean JM, Miklos D, et al. Induction of GADD45 and JNK/SAPK-dependent apoptosis following inducible expression of BRCAL Cell 1999;97:575-86.
16. Araki E, Murakami T, Shirotani T, et al. A cluster of four Sp1 binding sites required for efficient expression of the human insulin receptor gene. J Biol Chem 1991;266:3944-8.
17. Hankinson SE, Willett WC, Colditz GA, et al. Circulating concentrations of insulin-like growth factor-I and risk of breast cancer. Lancet 1998;351:1393-6.
18. Liu JL, LeRoith D. Insulin-like growth factor I is essential for postnatal growth in response to growth hormone. Endocrinology 1999;140:5178-84.
19. Mathews LS, Hammer RE, Brinster RL, et al. Expression of insulin-like growth factor I in transgenic mice with elevated levels of growth hormone is correlated with growth. Endocrinology 1988;123:433-7.
20. Sjogren K, Liu JL, Blad K, et al. Liver-derived insulin-like growth factor I (IGF-I) is the principal source of IGF-I in blood but is not required for postnatal body growth in mice. Proc Natl Acad Sci U S A 1999;96:7088-92.
21. Koda M, Sulkowska M, Kanczuga-Koda L, et al. Expression of the insulin receptor substrate 1 in primary tumors and lymph node metastases in breast cancer: correlations with Bcl-xL and Bax proteins. Neoplasma 2005;52:361-3.
22. Lee PD, Giudice LC, Conover CA, et al. Insulin-like growth factor binding protein-1: recent findings and new directions. Proc Soc Exp Biol Med 1997;216:319-57.
23. Gay E, Seurin D, Babajko S, et al. Liver-specific expression of human insulin-like growth factor binding protein-1 in transgenic mice: repercussions on reproduction, ante- and perinatal mortality, and postnatal growth. Endocrinology 1997;138:2937-47.
24. Rajkumar K, Barron D, Lewitt MS, et al. Growth retardation and hyperglycemia in insulin-like growth factor binding protein-1 transgenic mice. Endocrinology 1995;136:4029-34.
25. Schneider MR, Lahm H, Wu M, et al. Transgenic mouse models for studying the functions of insulin-like growth factor-binding proteins. FASEB J 2000;14:629-40.
26. Martin DC, Fowlkes JL, Babic B, et al. Insulin-like growth factor II signaling in neoplastic proliferation is blocked by transgenic expression of the metalloproteinase inhibitor TIMP-1. J Cell Biol 1999;146:881-92.
27. Lee AV, Taylor ST, Greenall J, et al. Rapid induction of IGF-IR signaling in normal and tumor tissue following intravenous injection of IGF-I in mice. Horm Metab Res 2003;35:651-5.
28. Maor SB, Abramovitch S, Erdos MR, et al. BRCA1 suppresses insulin-like growth factor-I receptor promoter activity: potential interaction between BRCA1 and Sp1. Mol Genet Metab 2000;69:130-6.
29. Abramovitch S, Glaser T, Ouchi T, et al. BRCA1-1 interactions in transcriptional regulation of the IGF-IR gene. FEBS Lett 2003;541:149-54.
30. Werner H, Shalita-Chesner M, Abramovitch S, et al. Regulation of the insulin-like growth factor-I receptor gene by oncogenes and antioncogenes: implications in human cancer. Mol Genet Metab 2000;71:315-20.
31. Brodie SG, Xu X, Qiao W, et al. Multiple genetic changes are associated with mammary tumorigenesis in Brcal conditional knockout mice. Oncogene 2001;20:7514-23.
32. Araki E, Haag BL III, Matsuda K, et al. Characterization and regulation of the mouse insulin receptor substrate gene promoter. Mol Endocrinol 1995;9:1367-79.
33. Mauro L, Salerno M, Panno ML, et al. Estradiol increases IRS-1 gene expression and insulin signaling in breast cancer cells. Biochem Biophys Res Commun 2001;288:685-9.
34. He H, Lehming N. Global effects of histone modifications. Brief Funct Genomic Proteomic 2003;2:234-43.
35. Ibrahim YH, Yee D. Insulin-like growth factor-I and breast cancer therapy. Clin Cancer Res 2005;11:944-50s.
36. Bahr C, Groner B. The IGF-I receptor and its contributions to metastatic tumor growth-novel approaches to the inhibition of IGF-IR function. Growth Factors 2005;23:1-14.
37. Cozzi R, Barausse M, Lodrini S, et al. Estroprogestinic pill normalizes IGF-I levels in acromegalic women. J Endocrinol Invest 2003;26:347-52.
38. Torrisi R, Baglietto L, Johansson H, et al. Effect of raloxifene on IGF-I and IGFBP-3 in postmenopausal women with breast cancer. BrJ Cancer 2001;85:1838-41.
39. Shi Y, Yan H, Frost P, et al. Mammalian target of rapamycin inhibitors activate the AKT kinase in multiple myeloma cells by up-regulating the insulin-like growth factor receptor/insulin receptor substrate-1/ phosphatidylinositol 3-kinase cascade. Mol Cancer Ther 2005;4:1533-40.
40. Kim DS, Kim SY, Kleuser B, et al. Sphingosine-1-phosphate inhibits human keratinocyte proliferation via Akt/protein kinase B inactivation. Cell Signal 2004;16:89-95.
41. Kiely PA, Leahy M, O'Gorman D, et al. RACK1-mediated integration of adhesion and insulin-like growth factor I (IGF-I) signaling and cell migration are defective in cells expressing an IGF-I receptor mutated at tyrosines 1250 and 1251. J Biol Chem 2005;280:7624-33.
42. 1-integrin and phosphatidylinositol 3′-kinase/AKT signaling. Cancer Res 2003;63:5850-8.
43. Andre F, Rigot V, Thimonier J, et al. Integrins and E-cadherin cooperate with IGF-I to induce migration of epithelial colonic cells. Int J Cancer 1999;83:497-505.
44. Kornberg LJ, Shaw LC, Spoerri PE, et al. Focal adhesion kinase overexpression induces enhanced pathological retinal angiogenesis. Invest Ophthalmol Vis Sci 2004;45:4463-9.
45. Kabir-Salmani M, Shiokawa S, Akimoto Y, et al. The role of a(5)β(1)-integrin in the IGF-I-induced migration of extravillous trophoblast cells during the process of implantation. Mol Hum Reprod 2004;10:91-7.
46. Zelzer E, Levy Y, Kahana C, et al. Insulin induces transcription of target genes through the hypoxiainducible factor HIF-1α/ARNT. EMBO J 1998;17:5085-94.
47. Tatar M, Bartke A, Antebi A. The endocrine regulation of aging by insulin-like signals. Science 2003;299:1346-51.
48. Katic M, Kahn CR. The role of insulin and IGF-1 signaling in longevity. Cell Mol Life Sci 2005;62:320-43.
49. Urnov FD. Chromatin remodeling as a guide to transcriptional regulatory networks in mammals. J Cell Biochem 2003;88:684-94.
50. Zeitlinger J, Simon I, Harbison CT, et al. Programspecific distribution of a transcription factor dependent on partner transcription factor and MAPK signaling. Cell 2003;113:395-404.